Treatment of heart failure

Impact on sudden death
  • J. Guindo
  • A. Bayés de Luna
  • P. Torner
  • J. Bartolucci
  • R. Estiarte
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 110)


Heart failure is the final situation in the natural history of the majority of heart diseases. Once the first signs or symptoms appear the prognosis clearly worsens.


Heart Failure Congestive Heart Failure Chronic Heart Failure Sudden Death Ventricular Arrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kannel WB, Plehn JF, Cupples LA: Cardiac failure and sudden death in the Framingham study. Am Heart J 1988;115:869.PubMedCrossRefGoogle Scholar
  2. 2.
    Likoff MJ, Chandler SL, Kay HR: Clinical determinats of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634.PubMedCrossRefGoogle Scholar
  3. 3.
    Cohn JN: Current therapy of the failing heart. Circulation 1988;78:1099.PubMedCrossRefGoogle Scholar
  4. 4.
    Packer M: Sudden unexpected death in patients with congestive heart failure: A second frontier. Circulation 1985;72:681.PubMedCrossRefGoogle Scholar
  5. 5.
    Bigger JT: Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987;75:IV-28.Google Scholar
  6. 6.
    Maskin CS, Siskind SJ, LeJemtel TH: High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J 1984;107:896.PubMedCrossRefGoogle Scholar
  7. 7.
    Sakurai T, Kawai C: Sudden death in idiopathic cardiomyopathy. Jpn Circ J 1983;47:581.PubMedCrossRefGoogle Scholar
  8. 8.
    Massie B, Ports T, Chatterjee K, Parmley W, Ostland J, O’Young J, Haughom F: Longterm vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation 1981;63:269.PubMedCrossRefGoogle Scholar
  9. 9.
    Lee WH, Packer M: Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilson JR, Schwartz JS, Sutton MS-J, Ferraro N, Horowitz LN, Reichek N, Josephson ME: Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 1983;2:403.PubMedCrossRefGoogle Scholar
  11. 11.
    Von Olshausen K, Schafer A, Mehmel HC, Schwartz F, Senges J, Kubler W: Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 1984;51:195.CrossRefGoogle Scholar
  12. 12.
    Franciosa JA, Wilen M, Ziesche SM, Cohn JN: Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:831.PubMedCrossRefGoogle Scholar
  13. 13.
    Huang SK, Messer JV, Denes P: Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983;51:507.PubMedCrossRefGoogle Scholar
  14. 14.
    Francis GS: Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 1986;57:3B.Google Scholar
  15. 15.
    Chakko CS, Gheorghiade M: Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985;109:497.PubMedCrossRefGoogle Scholar
  16. 16.
    Meinertz T, Hofman T, Kasper W, Treese M, Bechtold H, Stienen U, Pop T, Leitner E-RV, Andersen D, Meyer J: Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984;53:902.PubMedCrossRefGoogle Scholar
  17. 17.
    Holmes J, Kubo SH, Cody RI, Kligfield P: Arrhythmias in ischemic and non-ischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146.PubMedCrossRefGoogle Scholar
  18. 18.
    Bayés de Luna A, Guindo Soldevila J: Muerte súbita de origen cardiaco. Ed Doyma, Barcelona 1989.Google Scholar
  19. 19.
    Bayés de Luna A, Guindo J. Muerte stibita de origen cardiaco. Med Clin 1989;92:630.Google Scholar
  20. 20.
    Guindo J, Bayés de Luna A: Muerte Stibita en la cardiopatia isquémica. Rev Esp Cardiol 1989;42:116.PubMedGoogle Scholar
  21. 21.
    Cohn JN: Current therapy of the failing heart. Circulation 1988;78:1099.PubMedCrossRefGoogle Scholar
  22. 22.
    Cohn JN: Current therapy for heart failure. Am J Med 1988;84:51.CrossRefGoogle Scholar
  23. 23.
    Packer M: Therapeutic options in the management of chronic heart failure. Circulation 1989;79:198.PubMedCrossRefGoogle Scholar
  24. 24.
    Francis GS: Heart failure management: the impact of drug therapy on survival. Am Heart J 1988;115:699.PubMedCrossRefGoogle Scholar
  25. 25.
    Timmis A: Modern treatment of heart failure. Br Med J 1988;297:83.CrossRefGoogle Scholar
  26. 26.
    Packer M: Physiologic determinants of survival in congestive heart failure. Circulation 1987;75(supp IV):1–3.Google Scholar
  27. 27.
    Cohn JN: New concepts in the mechanisms and treatment of congestive heart failure. Am J Cardiol 1985;55:1A.Google Scholar
  28. 28.
    Cohn JN, Swedberg K, Kjekshus J: Advances in congestive heart failure. Am J Cardiol 1988;62:1A.CrossRefGoogle Scholar
  29. 29.
    Parmley WW, Ryden L: Congestive heart failure. Advances in treatment. Am J Cardiol 1989;63:1D.PubMedCrossRefGoogle Scholar
  30. 30.
    Riegger AJG, Kochsiek K, Robertson JIS: New aspects of therapy in heart failure. Eur Heart J 1988;9(supp H):1.Google Scholar
  31. 31.
    Prati PL, Tavazzi L: Scompenso cardiaco 1988. G Ital Cardiol 1988;18:1045.Google Scholar
  32. 32.
    Cohn TN: Indications for digitalis therapy — a newlook. JAMA 1974;229:1911.PubMedCrossRefGoogle Scholar
  33. 33.
    Captopril-digoxin multicenter research group: Comparative effects of therapy with captopril and digoxin in patients with mild or moderate heart failure. JAMA 1988;259:539.CrossRefGoogle Scholar
  34. 34.
    Guyatt, GH, Sullivan MJJ, Fallen EL, Tihal H, Rideout E, Halcrow S, Nogradi S, Townsend M, Taylor W: A controlled trial of digoxin in congestive heart failure. Am J Card 1988;61:371.PubMedCrossRefGoogle Scholar
  35. 35.
    Lee DC-S, Johnson RA, Bingham JB, Leahy M, Dinsmore RE, Goroll AH, Newell JB, Strauss W, Haber E: Heart failure in outpatients. N Engl J Med 1982;306:699.PubMedCrossRefGoogle Scholar
  36. 36.
    Cohn JN: Inotropic therapy for heart failure. N Engl J Med 1989;320:729.PubMedCrossRefGoogle Scholar
  37. 37.
    Moss AJ, Davis HT, Conard DL, DeCamilla JJ, Odoroff, ChL: Digitalis-associated cardiac mortality after myocardial infarction. Circulation 1981;64:1150.PubMedCrossRefGoogle Scholar
  38. 38.
    DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677.PubMedCrossRefGoogle Scholar
  39. 39.
    Sonnenblick EH: The role of phosphodiesterase III. Inhibitors in Contemporary cardiovascular medicine Am J Cardiol 1989;63:1A.Google Scholar
  40. 40.
    Packen M: Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing type from hope. J Am Coll Cardiol 1988;12:1299.CrossRefGoogle Scholar
  41. 41.
    Packer M: Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure. Am J Cardiol 1989;63:41A.Google Scholar
  42. 42.
    Packer M: Do vasodilators prolong life in heart failure? N Engl J Med 1987;316:1471.PubMedCrossRefGoogle Scholar
  43. 43.
    Furberg CD, Yusuf S: Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol 1985;55:1110.PubMedCrossRefGoogle Scholar
  44. 44.
    Domingo E, Lupón Rosés J: Vasodilatadores e insuficiencia cardiaca. Med Clin 1988;90:110.Google Scholar
  45. 45.
    Parker JO, Fung H-L, Ruggirello D, Stone JA: Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation 1983;68:1074.PubMedCrossRefGoogle Scholar
  46. 46.
    Franciosa JA, Cohn JN: Sustained hemodynamic effects without tolerance during longterm isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 1980;45:648.PubMedCrossRefGoogle Scholar
  47. 47.
    Pierpont GL, Cohn JN, Franciosa JA: Combined oral hydralazine-nitrate therapy in left ventricular failure: Hemodynamic equivalency to sodium nitroprusside. Chest 1978;73:8.PubMedCrossRefGoogle Scholar
  48. 48.
    Sharpe DN: Clinical evidence of benefit from angiotensin converting enzyme inhibitors in heart failure. Cur Opin Cardiol 1988;3(suppl 1):S83.CrossRefGoogle Scholar
  49. 49.
    Magnani B: Converting enzyme inhibition and heart failure. Am J Cardiol 1988;84(suppl 3A):87.Google Scholar
  50. 50.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman, WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;314:1547.PubMedCrossRefGoogle Scholar
  51. 51.
    Levine TB, Olivari MT, Garberg V, Sharkey SW, Cohn JN: Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Circulation 1984;69:548.PubMedCrossRefGoogle Scholar
  52. 52.
    CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med 1987;316:1429.CrossRefGoogle Scholar
  53. 53.
    Pfeffer MA, Pfeffer JM, Steinberg C, Finn P: Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406.PubMedCrossRefGoogle Scholar
  54. 54.
    Pfeffer JM, Pfeffer MA, Braunwald E: Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation 1978;75 (suppl I):I-149.Google Scholar
  55. 55.
    Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Eng J Med 1988;319:80.CrossRefGoogle Scholar
  56. 56.
    Newman TJ, Maskin CS, Dennick LG, Meyer JH, Hallows BG, Cooper WH: Effects of captopril on survival in patients with heart failure. Am J Med 1988;85(suppl 3A):140.CrossRefGoogle Scholar
  57. 57.
    Packer M, Lee WH, Yushak M, Medina N: Comparación entre captopril y enalapril en pacientes con insuficiencia cardiaca crónica severa. N Engl J Med 1986;315:847.PubMedCrossRefGoogle Scholar
  58. 58.
    Unverferth DV, Magorien RD, Moechsberger ML et al.: Factors influencing one year mortality of dilated cardiomyopathy. Am J Cardiol 1984; 54: 147.PubMedCrossRefGoogle Scholar
  59. 59.
    Meeting of the minds: Treatment of arrhythmias in congestive heart failure. Am Heart J 1987;114:1265.CrossRefGoogle Scholar
  60. 60.
    Bigger JT: Management of Ventricular arrhythmias in patients with congestive heart failure. Am J Car 1986;57:1B.CrossRefGoogle Scholar
  61. 61.
    Meinertz T, Hofmann T, Hohnloser, SH: Zehender M, Just H. Arrhythmias and left ventricular dysfunction. J Amb Mon 1989;2:66.Google Scholar
  62. 62.
    Cleland JGF, Dargie HJ: Arrhythmias, catecholamines and electrolytes. Am J Cardiol 1988;62:55A.Google Scholar
  63. 63.
    Parmley WW, Chatterjee K: Congestive heart failure and arrhythmias: an overview. Am J Cardiol 1986;57:34B.Google Scholar
  64. 64.
    Gomes JAC, Hariman RI, Kang PS, El-Sherif N, Chowder Lyons J: Programmed electrical stimulation in patients with high grade ventricular ectopy: electrophysiological findings and prognosis for survival. Circulation 1984;70:43.PubMedCrossRefGoogle Scholar
  65. 65.
    Poll DS, marchlinksi FE, Buxton AE, Doherty JU, Waxman HL, Josephson ME: Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 1984;70:451.PubMedCrossRefGoogle Scholar
  66. 66.
    Wilson JR: Use of antiarrhythmic drugs in patients with heart failure: clinical efficacy, hemodynamic results and relation to survival. Circulation 1987;75(suppl IV):IV-64.Google Scholar
  67. 67.
    CAST Investigators. Preliminary Report: effect of encainide and flecainide on mortality in a randomised trial of arrhythmia supression after myocardial infarction. N Engl J Med 1989;321:406.CrossRefGoogle Scholar
  68. 68.
    Grupo investigador del EEMS: Ensayo clinico multicéntrico sobre la prevención de la muerte súbita con agentes antiarrítmicos en el postinfarto de miocardio. Rev Esp Cardiol 1989;42:77.Google Scholar

Copyright information

© Kluwer Academic Publishers 1991

Authors and Affiliations

  • J. Guindo
  • A. Bayés de Luna
  • P. Torner
  • J. Bartolucci
  • R. Estiarte

There are no affiliations available

Personalised recommendations